Etiopathogenesis

Secondary pulmonary TB infection is the cause of genital infection. It typically affects immunocompromised individuals and spreads directly via the hematogenous or lymphatic channels. It also occurs in individuals who have been afflicted by chronic illnesses like HIV and coronavirus disease 2019 (COVID-19). During sexual contact with a male partner who has genitourinary TB (GUTB), a rare primary infection, genital TB can be directly transmitted. It has been reported that the infection quickly spread from the vulva, cervix, and vagina.

Clinical manifestations

The majority of cases of genital tuberculosis have been reported in infertile individuals aged 20 to 45. Genital tuberculosis can manifest in a variety of clinical signs, but it is typically asymptomatic and is initially discovered during infertility tests. Infertility is the most common symptom that is seen; Additional symptoms include pain in the pelvic area, abnormal vaginal discharge, and irregular changes in the menstrual cycle (such as hypomenorrhea, heavy menstrual bleeding, dysmenorrhea, and metrorrhagia). It can also be asymptomatic at times.

Causes of infertility

In almost all cases of FGTB, one or both of the fallopian tubes are affected, resulting in infection, inflammation, and tube obstruction. Asherman’s syndrome, which causes continuous endometrial destruction and the development of synechiae inside the uterus, further increases the hostility of the uterine endometrium by increasing levels of tumor necrosis factor (TNF)-alpha and IL-2, resulting in latent FGTB, which causes recurrent implantation failure and miscarriages. TB can also destroy the ovaries and cause oophoritis, a condition in which the ovary has less reserve and needs more gonadotropins to start the ovulation process.

Investigations: Imaging techniques for typical structural abnormalities are essential for the diagnosis of tuberculosis, and several tests are used to confirm the infection. The WHO states that a single specimen with a positive culture, a positive histology result, or significant clinical evidence of active extrapulmonary TB is required to confirm the diagnosis of extrapulmonary TB.

Medical Treatment

FGTB treatment lasts for a total of six months, just like pulmonary TB treatment. Four oral medications—rifampicin (R), isoniazid (H), pyrazinamide (Z), and ethambutol (E)—are given during the first two months of the intensive phase. For the next four months, a three-drug regimen was used in the continuation phase instead of the previous two: isoniazid (I), rifampicin (R), and ethambutol (E). An extended oral regimen for 18 to 20 months or a shorter regimen for at least 9 to 12 months is prescribed for individuals with primary or secondary FGTB who are drug-resistant.

Anti-tubercular therapy (ATT) is recommended as a treatment option for FGTB due to the numerous risks associated with surgery. The drainage of the abscess is the only type of limited surgery that can be performed. However, diagnostic laparoscopy and hysteroscopy are carried out initially for diagnosis and later for prognosis prediction. Then, after the TB treatment is finished, more infertility treatment can be given.

Primary TB prevention includes measures to lessen the likelihood of coming into contact with mycobacteria. As a result, patients with pulmonary tuberculosis must be advised to continue receiving the prescribed treatment and to practice good respiratory hygiene both at home and in public settings. Safe sex practices can lower the risk of genital infections, particularly genital tuberculosis. In countries with a high prevalence of tuberculosis, such as India, the BCG vaccine is used as a preventative measure. Although the BCG vaccination can prevent the onset of advanced TB up to 80% of the time, its effectiveness as a preventative measure varies significantly between demographic groups.

Read Also: https://www.artbaby.in/2026/09/28/genital-tuberculosis-and-ivf-can-pregnancy-still-be-achieved/

Reference:

https://www.cureus.com/articles/109199-tuberculosis-in-the-female-genital-tract#!/

The post Genital tuberculosis   appeared first on ARTbaby IVF Centre.

Modern genetic testing has made it possible to identify chromosome patterns in embryos that were previously difficult to detect. However, a mosaic PGT-A result does not automatically mean that the entire embryo is abnormal. For international IVF patients, understanding what the result means and what it does not mean is especially important before making a transfer decision.

What Is Embryo Mosaicism?

Embryo mosaicism refers to the presence, or suspected presence, of cells with different chromosome patterns within an embryo.

During PGT-A, a few cells are removed from the trophectoderm, the outer layer of a blastocyst that contributes mainly to the placenta. The inner cell mass, which develops into the fetus, is not directly tested. Therefore, a mosaic result from the biopsy does not necessarily tell us the chromosome status of every cell in the embryo.

ASRM notes that intermediate chromosome-copy results may have several explanations, including true mosaicism, technical variation, amplification bias, contamination and differences in biopsy or laboratory procedures.

Why Does PGT-A Report Mosaic Results?

PGT-A is a laboratory screening that uses genetic testing to assess an embryo for the expected number of chromosomes.

Modern testing methods can identify intermediate or mixed signals in the biopsy sample. Depending on the laboratory’s testing platform and reporting thresholds, these findings may be reported as mosaic or suggestive of mosaicism. This is why two laboratories may not always classify exactly the same genetic finding in the same way.

ESHRE recommends that reports clearly explain the technical and biological limitations of detecting mosaicism.

Does a Mosaic Embryo Mean a Baby Will Have a Chromosomal Condition?

Not necessarily. This is one of the most important points for patients to understand. Mosaic embryos have resulted in ongoing pregnancies and healthy births. At the same time, studies suggest that some mosaic-result embryos may have lower implantation rates and higher miscarriage rates than embryos classified as euploid.

ASRM’s review of available evidence found that the rate of fetal or neonatal confirmation of the same chromosomal abnormality reported in the mosaic PGT-A result was less than 1% in the published data available for its 2023 committee opinion. However, this should not be interpreted as a guarantee of a healthy outcome for an individual pregnancy.

Low-Level and High-Level Mosaicism

You may see terms such as low-level mosaic or high-level mosaic on a PGT-A report. These terms generally describe the proportion of abnormal signal detected in the tested biopsy. However, the percentage should not be interpreted as the percentage of abnormal cells in the entire embryo.

Importantly, ASRM states that there is currently no evidence-based method for predicting an individual embryo’s outcome simply by ranking mosaic embryos according to these characteristics. ESHRE has also highlighted that evidence is insufficient to provide firm recommendations for high-range mosaic embryo transfer.

Can a Mosaic Embryo Be Transferred?

In some circumstances, the answer is yes. The decision depends on the individual PGT-A result, the availability of euploid embryos, embryo morphology, the patient’s reproductive history, and the policies of the fertility clinic.

ESHRE recommends that, when considering embryos with euploid and low-range mosaic results, the PGT-A result should be considered together with embryo morphology rather than used alone.

However, patients should not assume that every mosaic embryo carries the same potential. The chromosome involved and the type of result can influence clinical discussions, but current evidence does not allow doctors to predict the outcome with certainty.

What Are the Main Concerns With Mosaic Embryo Transfer?

Patients should discuss several issues with their fertility specialist and genetic counselor:

• Implantation: Some studies report lower implantation rates than with euploid embryos.
• Miscarriage: Certain mosaic-result embryos have been associated with higher miscarriage rates.
• Chromosomal outcome: A small number of pregnancies have shown chromosomal findings related to the original PGT-A result.
• Testing limitations: The biopsy represents only a small sample of the embryo.
• Uncertainty: Long-term data remain limited compared with euploid embryo transfers.

These uncertainties are why the decision should be individualized rather than based on a single number or label.

What Should International Patients Consider?

For patients travelling across borders for IVF, there is an additional layer of complexity.

Different countries and fertility centres may have different policies regarding:

• Reporting of mosaic PGT-A results
• Classification of low- and high-level mosaicism
• Embryo transfer policies
• Genetic counselling
• Prenatal testing
• Storage or disposition of mosaic embryos

If an embryo is being transported between countries or fertility centres, patients should obtain the complete original PGT-A report and laboratory methodology.

This information can be important because terminology and reporting thresholds may differ between laboratories. ESHRE specifically recommends that technical information be available when embryos are transferred between centers.

Questions to Ask Before Transferring a Mosaic Embryo

Before making a decision, international patients can ask:

1. What exactly does a PGT-A report say?
2. Which chromosome is involved?
3. Is the result whole-chromosome or segmental?
4. How does this laboratory define mosaicism?
5. Was the result obtained from a trophectoderm biopsy?
6. Are any euploid embryos available?
7. How does embryo morphology compare with the other available embryos?
8. What prenatal testing would be recommended if pregnancy occurs?
9. Should we meet a genetic counselor before transfer?
10. Will the PGT-A laboratory provide its technical report if the embryo is moved to another country?

Should a Mosaic Embryo Be Re-Biopsied?

Re-biopsy may seem like an obvious way to obtain a clearer answer, but it is not automatically recommended.

ESHRE states that re-biopsy of embryos with a mosaic trophectoderm result for the purpose of confirming ploidy is not recommended because evidence has not demonstrated diagnostic value and additional biopsy may potentially affect embryo development.

The decision should therefore be discussed with the treating embryologist and reproductive specialist rather than undertaken routinely.

What Happens If Pregnancy Occurs?

A mosaic PGT-A result does not end the discussion once pregnancy is established. Patients should receive prenatal genetic counseling to understand available screening and diagnostic options.

ASRM recommends prenatal genetic counseling and appropriate prenatal testing for pregnancies following mosaic embryo transfer. The exact approach should be determined by the obstetrician and genetics team based on the embryo’s PGT-A result and the pregnancy.

The Most Important Message for Patients

A mosaic PGT-A result is not the same as a diagnosis of an abnormal baby. At the same time, it should not be treated as equivalent to a confirmed euploid result.

It represents a complex finding from a limited embryo biopsy, and both its biological meaning and clinical significance can vary. For international patients, the best approach is to obtain the complete laboratory report, understand the testing method, discuss the result with a reproductive specialist and seek specialist genetic counseling before making the transfer decision.

Final Takeaway

Embryo mosaicism has changed how fertility specialists think about embryo selection. Some embryos reported as mosaic can implant and result in healthy births, while research also shows differences in implantation and miscarriage outcomes compared with euploid embryos. Therefore, “mosaic” should not automatically mean “discard,” but it should also not be interpreted as “normal.”

For international IVF patients, informed decision-making is particularly important because testing methods, reporting terminology and clinical policies may differ between countries and laboratories.

The goal is not simply to find a perfect-looking genetic report. It is to understand the available evidence, recognize the uncertainty and make a carefully informed decision together with the fertility, embryology and genetics team.

The post Embryo Mosaicism: What Patients Should Know Before Making a Transfer Decision? appeared first on ARTbaby IVF Centre.

This is where the idea of a 90-day sperm improvement plan before IVF becomes useful. It is not a guarantee that sperm parameters will become normal in three months, but it provides a practical period in which potentially modifiable factors can be addressed before treatment.

Why 90 Days Matters for Sperm Health

Sperm production is a continuous biological process. Changes in health and lifestyle do not necessarily appear immediately in a semen sample.

A roughly three-month preparation period is therefore commonly used clinically to reassess sperm-related factors after lifestyle or medical interventions. The exact timing should be individualized by a fertility specialist.

The WHO 6th edition semen manual provides standardized methods for semen examination and processing, helping laboratories produce more consistent and clinically useful results.

Importantly, semen analysis is not a simple “fertile” or “infertile” test. It provides information about sperm concentration, movement and morphology, but fertility depends on the couple as a whole.

Male Infertility in India: A Changing Conversation

For many years, infertility in India was socially associated predominantly with women. Men were often tested later, or not tested at all.

This approach is changing.

Indian urological guidelines emphasize simultaneous evaluation of both partners. Male factors may include abnormal sperm production, varicocele, hormonal disorders, obstruction, infections, genetic conditions, sexual or ejaculatory problems and environmental or lifestyle factors.

Lifestyle-related factors such as obesity, smoking, alcohol consumption, poor sleep and exposure to environmental pollutants have also been associated with impaired semen parameters, although the strength of evidence varies between individual factors.

Greater awareness is helping Indian couples seek male infertility testing earlier, rather than viewing IVF as a treatment directed only at the woman.

Your 90-Day Sperm Health Plan

Days 1-30: Find the Cause Before Trying to Fix It

The first month should focus on evaluation, not supplements.

1. Start with a proper semen analysis

A semen analysis can assess:

• Semen volume
• Sperm concentration
• Total sperm number
• Motility
• Progressive motility
• Morphology
• Other laboratory parameters where indicated

Testing should be performed by a quality-controlled laboratory using standardized methodology. The WHO manual specifically emphasizes laboratory quality assurance and standardized semen examination.

An abnormal result does not automatically mean that IVF or ICSI will be required.

If the first analysis is abnormal, your fertility specialist may recommend repeat testing and additional evaluation.

2. Look for treatable causes

Depending on the history and semen findings, evaluation may include:

• Physical examination by an andrologist/urologist
• Hormonal testing
• Assessment for varicocele
• Evaluation for reproductive-tract infection when clinically indicated
• Genetic testing in selected cases of severe sperm abnormalities or azoospermia
• Assessment for obstruction
• Review of previous surgery, trauma or medical treatment

The aim is to identify why sperm parameters are abnormal, rather than simply treating the laboratory report.

Days 31-60: Improve Modifiable Factors

The second month is about creating conditions that support reproductive health.

3. Stop smoking and tobacco use

Smoking is associated with adverse reproductive effects and poorer semen parameters. Stopping is one of the most meaningful lifestyle changes a man can make before attempting conception or IVF.

This includes cigarettes and other tobacco products.

4. Maintain a healthy weight

Excess weight and metabolic disorders may negatively influence reproductive health.

A sustainable approach is better than crash dieting:

• Eat a varied, nutrient-rich diet
• Increase vegetables, fruits and whole grains
• Include adequate protein
• Choose healthier sources of unsaturated fats
• Limit highly processed foods and excessive added sugar
• Maintain regular physical activity

WHO’s 2025 infertility guidance supports low-cost lifestyle counseling around diet, physical activity and weight management for people undergoing infertility care, while acknowledging that the certainty of evidence for specific lifestyle interventions is limited.

5. Moderate alcohol and avoid recreational drugs

Excessive alcohol intake and recreational drug use can negatively affect reproductive health. Men preparing for IVF should discuss their alcohol and substance use honestly with their fertility specialist.

6. Prioritize sleep and stress management

Chronic psychological stress and sleep problems have been associated with poorer reproductive health, although individual responses differ.

Aim for:

• Consistent sleep
• Regular exercise
• Stress-reduction practices
• Reasonable working hours where possible

The goal is not to create a “perfect” lifestyle. It is to reduce avoidable reproductive-health risks.

Days 61-90: Reassess and Prepare for IVF

By the third month, the focus shifts from general health to treatment planning.

7. Review medications and supplements

Some medications can affect sperm production. Of particular importance is testosterone therapy.

Men sometimes use testosterone injections or supplements for low testosterone, muscle development or sexual health without realizing that external testosterone can suppress sperm production.

Never stop prescribed medication independently. Instead, tell your fertility specialist about:

• Testosterone therapy
• Steroids
• Prescription medicines
• Over-the-counter products
• Herbal preparations
• Fertility supplements

The clinician can determine whether anything needs to be changed.

8. Don’t assume that more supplements mean better sperm

Antioxidant and micronutrient supplements are widely marketed for male fertility. However, evidence for routine supplementation is inconsistent, and not every man with infertility needs them.

A supplement should therefore be considered only after medical assessment, rather than replacing diagnosis or evidence-based treatment.

What If Sperm Quality Does Not Improve?

Not every case of male infertility is caused by lifestyle. Some conditions require targeted medical treatment. Depending on the diagnosis, Indian fertility centers may offer approaches such as:

• Treatment of an identified hormonal disorder
• Management of varicocele in appropriately selected patients
• Treatment of infections where indicated
• Surgical correction of selected obstructions
• Sperm cryopreservation
• IVF
• Intracytoplasmic sperm injection (ICSI)
• Surgical sperm retrieval such as TESA/TESE or related procedures when indicated
• Genetic counseling and testing for selected patients

ICSI can allow fertilization using a single sperm injected directly into an egg and is particularly relevant when severe male-factor infertility makes conventional fertilization difficult.

However, ICSI is not automatically superior for every IVF patient. The treatment should be selected according to the couple’s diagnosis, previous treatment history and clinical circumstances.

What About Sperm DNA Fragmentation?

Some fertility centers offer sperm DNA fragmentation testing, particularly in selected cases such as repeated IVF failure or certain male-factor presentations.

DNA fragmentation assesses sperm DNA integrity rather than simply sperm count or movement.

It can provide additional information in specific clinical situations, but it should not be treated as a universal screening test for every man undergoing IVF. Your fertility specialist can determine whether the result is likely to change management.

The WHO semen manual also distinguishes routine semen assessment from advanced and research-oriented examinations, reinforcing the importance of interpreting advanced tests within the appropriate clinical context.

What Indian Couples Should Remember

A 90-day preparation period is not about achieving a “perfect” sperm count.

It is about asking better questions:

• Is there a treatable cause?
• Are there modifiable lifestyle factors?
• Does the semen analysis need to be repeated?
• Is additional testing justified?
• Which fertility treatment is appropriate for this couple?

Most importantly, male infertility should not be approached with blame or embarrassment.

Modern fertility care increasingly recognizes infertility as a couple’s medical issue, with male and female factors evaluated together. Indian clinical guidance specifically recommends concurrent assessment of both partners.

How ARTBaby Approaches Male-Factor Infertility

For couples considering IVF at ARTBaby, understanding the male partner’s reproductive health is an important part of individualized fertility planning.

A comprehensive assessment can help determine whether lifestyle modification, medical treatment, further investigation, IVF, ICSI or another approach is appropriate.

The objective is not simply to increase a number on a semen report. It is to identify the factors that may influence fertilization and develop a treatment strategy suited to the individual couple.

If you are preparing for IVF, starting the conversation about male fertility early can be just as important as preparing for ovarian stimulation.

Go through: our IVF Services

Key Takeaway

The 90-day sperm improvement plan should be viewed as a period for evaluation, healthier habits, and appropriate medical intervention, not as a guaranteed formula for improving IVF success.

When male-factor infertility is identified early and managed alongside female factors, couples can make more informed decisions about their fertility treatment.

Disclaimer

This article is intended for general educational purposes and does not replace consultation with a qualified fertility specialist, urologist, or andrologist. Sperm parameters and treatment requirements vary between individuals. No lifestyle change, supplement, or diagnostic test can guarantee IVF success. Medical decisions should be based on an individual’s clinical history and appropriate laboratory evaluation.

The post The 90-Day Sperm Improvement Plan Before IVF: Evidence-Based Steps That Matter appeared first on ARTbaby IVF Centre.

The challenge is that genital TB can remain silent. Some women have no obvious symptoms and discover the condition only during an infertility evaluation. This makes awareness particularly important when a couple is considering IVF treatment in India.

The good news is 00that a diagnosis of genital TB does not automatically mean that pregnancy is impossible. With appropriate diagnosis, treatment and fertility planning, assisted reproductive technology may provide a pathway to pregnancy for selected patients.

What Is Genital Tuberculosis

Genital tuberculosis is an extrapulmonary form of infection caused by Mycobacterium tuberculosis. In women, the infection commonly involves the fallopian tubes and endometrium, although other reproductive organs can also be affected.

The infection can reach the reproductive tract through the bloodstream or lymphatic system, often after an earlier or concurrent TB infection elsewhere in the body.

Importantly, GTB may occur without a clear history of pulmonary TB. Infertility can sometimes be its first recognized manifestation.

How Common Is Genital TB in Indian Women With Infertility?

There is no single national prevalence figure that accurately represents every Indian infertility patient. Published studies have reported substantial variation depending on the population, geographical region, and diagnostic criteria and whether patients were treated at tertiary referral centers.

Earlier Indian studies and reviews have reported GTB in approximately 3-16% of women evaluated for infertility, with considerably higher proportions reported in selected tertiary-care and tubal-factor infertility populations.

A recent Indian systematic review and meta-analysis also found a significant association between female genital TB and infertility, although the reported prevalence should not be interpreted as the prevalence among all Indian women.

This variation is important: a positive TB test or a history of TB alone does not establish genital TB, and indiscriminate testing or treatment is not appropriate.

How Can Genital TB Affect Fertility and IVF?

GTB can damage reproductive tissues through inflammation, scarring and fibrosis.

The consequences may include:

• Fallopian-tube blockage
• Pelvic adhesions
• Damage to the endometrium
• Intrauterine adhesions
• Reduced uterine receptivity
• Abnormal uterine anatomy
• Increased risk of ectopic pregnancy
• Reduced chances of implantation and pregnancy

Tubal damage is particularly important because the fallopian tubes are frequently involved in female genital TB.

Even after successful anti-tuberculosis treatment, structural damage may remain. In other words, eliminating the infection does not necessarily reverse the anatomical damage it has already caused. This distinction is critical when planning IVF.

Can IVF Work After Genital Tuberculosis?

Yes, pregnancy can be achieved after treated genital TB, but the outcome depends heavily on the extent of reproductive-tract damage and the woman’s overall fertility profile.

IVF can be particularly useful when tubal blockage or extensive pelvic damage makes natural conception difficult.

A recent systematic review and meta-analysis involving patients with treated genital TB found that IVF was associated with higher pregnancy rates than treatment alone in the analyzed studies. Importantly, the researchers also reported that patients with GTB undergoing IVF did not necessarily have significantly different pregnancy or live-birth outcomes compared with IVF patients with other infertility factors.

However, these findings should not be interpreted as a guarantee of IVF success. Studies differ considerably in patient selection, disease severity and diagnostic criteria.

Why Treating TB Before IVF Matters

Starting IVF while active or inadequately treated genital TB is suspected can create significant clinical concerns.

A contemporary review emphasizes that untreated genital TB should be identified and appropriately managed before attempting ART, because pregnancy following IVF can present additional maternal and fetal risks when TB is active.

Therefore, fertility treatment should generally follow a structured sequence:

1. Establish the diagnosis 

The fertility specialist may consider:

• Detailed medical and TB history
• Pelvic ultrasound
• Assessment of the uterine cavity
• Hysterosalpingography (HSG), where appropriate
• Hysteroscopy or laparoscopy in selected patients
• Microbiological or molecular testing when clinically indicated
• Tissue evaluation when appropriate

No single test can reliably diagnose every case of genital TB. Diagnosis can be challenging, particularly when the disease is paucibacillar or clinically silent.

2. Complete appropriate anti-TB treatment 

When genital TB is diagnosed or clinically established, treatment should be managed by an appropriate TB/infectious-disease specialist in coordination with the fertility team.

Anti-tuberculosis therapy is the cornerstone of treatment. The exact regimen and duration depend on the patient’s clinical circumstances and current national TB protocols.

Patients should never self start, stop or modify TB medication because inappropriate treatment can contribute to treatment failure and drug resistance.

3. Reassess reproductive anatomy 

After treatment, clinicians need to determine what damage remains.

This may include evaluating:

• Uterine cavity
• Endometrial condition
• Tubal status
• Pelvic adhesions
• Ovarian reserve
• Other infertility factors

The goal is not simply to ask, “Is the TB gone?” but also, “What has the previous infection done to reproductive function?”

4. Develop an individualized IVF strategy 

If significant tubal damage remains, IVF may bypass the need for normally functioning fallopian tubes.

However, the treatment plan may need to address uterine abnormalities or adhesions before embryo transfer.

A recent meta-analysis proposed reassessment following treatment and consideration of IVF particularly when structural abnormalities such as tubal blockage, intrauterine adhesions or pelvic adhesions persist.

What about a Thin or Damaged Endometrium?

Endometrial involvement can be particularly important because embryo implantation requires a suitable uterine environment.

Previous genital TB may cause:

• Endometrial scarring
• Intrauterine adhesions
• Reduced uterine cavity volume
• Menstrual abnormalities
• Difficulties with implantation

Therefore, simply retrieving good-quality eggs and creating embryos may not be enough. The uterus also needs careful assessment before embryo transfer.

In selected patients, hysteroscopy may help diagnose and treat intrauterine adhesions, although the appropriate approach depends on the extent of disease.

Does Previous Genital TB Mean IVF Will Fail?

No. This is one of the most important messages for patients. The prognosis depends on several variables, including:

• Age
• Ovarian reserve
• Egg and embryo quality
• Extent of tubal damage
• Endometrial condition
• Presence of intrauterine adhesions
• Duration and severity of infertility
• Other male or female infertility factors
• Whether TB has been adequately treated

Some women with previous genital TB go on to achieve pregnancy through IVF, while others may require more complex reproductive planning.

The recent evidence is encouraging but also reinforces the importance of individualized counseling rather than promising a specific success rate.

What Should Indian IVF Patients Remember?

If you have previously had TB and are experiencing infertility, tell your fertility specialist about:

• Previous pulmonary or extrapulmonary TB.
• Previous anti-TB treatment and its duration.
• Any history of pelvic or genital TB.
• Menstrual changes or unusually scanty periods.
• Previous ectopic pregnancy or tubal disease.
• Previous infertility investigations or surgeries.
• Any previous IVF failures.

A history of TB does not mean that genital TB is definitely present, but it may help the fertility team decide whether further evaluation is appropriate.

ARTBaby: A Patient Centred Approach to Complex Infertility 

At ARTBaby, patients undergoing IVF can benefit from an approach that considers the underlying cause of infertility rather than focusing only on embryo transfer.

For patients with a history suggestive of genital TB, fertility planning may involve collaboration between reproductive medicine specialists and other appropriate medical specialists to establish disease status evaluate reproductive anatomy and determine when IVF is medically appropriate.

The objective is straightforward: treat the underlying condition, understand the reproductive damage, and then design the fertility pathway around the individual patient.

The Bottom Line 

Genital tuberculosis can cause substantial reproductive damage, particularly to the fallopian tubes and endometrium. But a previous diagnosis of genital TB is not synonymous with permanent infertility.

Modern fertility care can combine appropriate TB management, reproductive assessment, surgical intervention when indicated and IVF to give carefully selected patients a realistic opportunity to achieve pregnancy.

For Indian couples, early evaluation is especially valuable when infertility remains unexplained or there is a relevant history of tuberculosis.

References:

• https://pmc.ncbi.nlm.nih.gov/articles/PMC11976926/
• https://www.sciencedirect.com/science/article/pii/S2049080122011980

Disclaimer:

This article is intended for general educational purposes and does not replace medical consultation, TB evaluation or individualized fertility advice. Genital TB diagnosis and treatment require specialist assessment, and IVF suitability should be determined by a qualified fertility specialist based on the patient’s medical history, investigations and current clinical condition.

The post Genital Tuberculosis and IVF: Can Pregnancy Still Be Achieved? appeared first on ARTbaby IVF Centre.

The emphasis comes as international fertility guidance increasingly recognizes preconception health as an important component of infertility care. The World Health Organization’s first global guideline on infertility, issued in November 2025, recommends lifestyle interventions such as a healthy diet, physical activity and tobacco cessation for individuals and couples planning pregnancy.

Moving Beyond IVF Alone

According to ARTBaby, lifestyle medicine should not be viewed as an alternative to IVF or other fertility treatments. Instead, it can complement medical evaluation by addressing health factors that may influence reproductive function and pregnancy readiness.

Evidence indicates that smoking, unhealthy body weight, poor dietary patterns and other lifestyle factors can affect reproductive health in both women and men. However, the relationship between lifestyle modification and IVF outcomes is complex, and patients should not be given unrealistic expectations that lifestyle changes alone will guarantee pregnancy or improve live-birth rates.

“Fertility care should look at the patient as a whole rather than focusing only on an individual test or procedure,” said ARTBaby. “Lifestyle assessment can help identify modifiable factors while allowing fertility specialists to determine whether medical treatment, IVF or other interventions are required.”

Why It Matters for Indian Couples

India’s diverse population presents unique challenges in implementing healthy lifestyle practices. Long working hours, sedentary routines, changing dietary patterns, obesity, diabetes, tobacco exposure and stress can influence overall reproductive health.

Women with conditions such as PCOS may particularly benefit from individualized lifestyle management. International PCOS guidance recognizes healthy eating, regular physical activity and maintenance of a healthy weight as important components of overall management and quality of life.

For men, lifestyle assessment is also relevant. Smoking, alcohol consumption, obesity and certain environmental exposures have been associated with poorer semen parameters. A fertility evaluation should therefore include both partners rather than placing the responsibility for infertility primarily on women.

What Lifestyle-Focused Fertility Care Can Include

Depending on an individual’s medical history, fertility specialists may discuss:

• Balanced nutrition and appropriate weight management
• Regular, moderate physical activity
• Tobacco cessation
• Appropriate alcohol reduction or avoidance
• Sleep and stress management
• Management of diabetes, thyroid disorders and other metabolic conditions
• Review of medications and supplements
• Male reproductive-health assessment and semen analysis
• Preconception counseling
• Appropriate medical or assisted reproductive treatment when required

The latest European Society of Human Reproduction and Embryology (ESHRE) guidance similarly recommends a healthy diet and regular exercise for patients with unexplained infertility, while noting that evidence does not establish a particular diet or exercise programme as a guaranteed way to improve assisted-reproduction outcomes.

Personalization Remains Essential

ARTBaby emphasizes that lifestyle recommendations should be individualized rather than based on generic fertility diets, supplements or internet trends.

For some patients, improving metabolic health may be particularly important. Others may require immediate fertility treatment because of age-related fertility decline, diminished ovarian reserve, severe male-factor infertility, tubal disease or other medical conditions.

Recent ESHRE recommendations also stress individualized IVF care, including consideration of patient characteristics, treatment response and safety when planning ovarian stimulation.

Lifestyle medicine therefore represents one component of fertility care, not a substitute for timely diagnosis or evidence-based treatment.

ARTBaby’s Patient-Centered Approach

ARTBaby encourages couples to discuss lifestyle, medical history and reproductive goals openly with their fertility team. Early assessment can help identify potentially modifiable factors while avoiding unnecessary delays in patients who may benefit from fertility treatment.

As fertility medicine continues to evolve, the integration of preconception health, clinical diagnostics, individualized treatment and evidence-based reproductive technology may provide a more comprehensive approach to fertility care in India.

About ARTBaby:

ARTBaby is a fertility-care platform focused on providing patients with information and access to individualized assisted reproductive care. Its approach emphasizes informed decision-making, clinical evaluation and patient-centered fertility treatment.

1. Disclaimer

This press release is intended for general educational and informational purposes only and does not constitute medical advice, diagnosis or a guarantee of fertility or IVF success. Lifestyle changes may support general and reproductive health, but their effect on fertility outcomes varies between individuals. Patients should consult a qualified fertility specialist before changing medications, starting supplements, undertaking significant weight-loss programs or making decisions about IVF or other fertility treatments.

The post ARTBaby Highlights the Growing Role of Lifestyle Medicine in Improving Fertility Outcomes appeared first on ARTbaby IVF Centre.

The short answer is yes, you can still achieve a healthy pregnancy with adenomyosis through In Vitro Fertilization (IVF). While adenomyosis adds a layer of complexity, targeted medical strategies and tailored treatment protocol adjustments allow many women with this condition to successfully conceive and carry healthy babies.

What Is Adenomyosis?

To understand how adenomyosis affects fertility, it helps to picture the structure of the uterus.

The uterus consists of two main layers:

1. The Endometrium: The inner lining that thickens every month and sheds during your period (or holds an embryo during pregnancy).
2. The Myometrium: The surrounding thick muscle wall that contracts during labor.

In a healthy uterus, there is an important border separating the inner lining from the muscle wall called the Junctional Zone. Think of it as an invisible protective barrier that keeps the endometrial lining strictly contained inside the uterine cavity where it belongs.

In adenomyosis, that protective boundary (the Junctional Zone) weakens and breaks down. When this happens, small bits of the inner lining burrow through the broken barrier and sink directly into the surrounding muscle wall. Instead of staying neatly on the surface where they belong, these tiny “islands” of lining tissue get trapped deep inside the muscle itself.

Every month during your menstrual cycle, this misplaced tissue behaves like normal lining. It thickens, breaks down, and bleeds. Because the blood has nowhere to go within the muscle wall, it leads to chronic inflammation, localized swelling, severe cramps, and heavy or prolonged bleeding.

Comparison

Why Adenomyosis Causes Pain, Heavy Bleeding, and Swelling

The real problem isn’t just that the tissue moved, but it’s that the misplaced tissue still acts like uterine lining, no matter where it is located.

Even though these tissue islands are trapped inside the muscle wall, they still respond to your monthly hormonal cycle:

1. Estrogen Rises: During the first half of your cycle, the trapped tissue inside the muscle wall thickens and expands, just like the lining inside your uterus does.
2. Hormones Drop: During your period, the trapped tissue attempts to bleed, just like your normal period.
3. No Way Out: Unlike normal menstrual blood that easily flows out through the cervix, this blood and fluid has nowhere to escape because it is completely surrounded by solid muscle.

How Does Adenomyosis Affect IVF and Fertility?

Adenomyosis can influence fertility and the outcome of IVF treatments in a few specific ways:

• Altered Uterine Environment: The chronic inflammation caused by misplaced tissue makes the uterine lining less receptive to an embryo.
• Impaired Embryo Implantation: Inflammation and subtle structural changes in the uterine wall can make it harder for an embryo to attach securely.
• Disrupted Uterine Contractions: A healthy uterus exhibits subtle, rhythmic waves that help transport sperm and position an embryo. Adenomyosis can cause irregular muscular contractions, potentially interfering with early implantation.
• Increased Risk of Early Pregnancy Loss: Studies published by the National Institutes of Health (NIH) indicate that untreated adenomyosis can slightly elevate the risk of miscarriage or early pregnancy complications due to reduced uterine elasticity and local inflammatory responses.

How Tailored IVF Protocols Help You Succeed

Having adenomyosis does not mean IVF won’t work. It simply means a standard approach may need adjustment. Reproductive specialists use targeted strategies to calm the uterine environment before introducing an embryo.

Key Medical Strategies to Improve Success:

1. Down-Regulation (Medical Suppression): Before performing an embryo transfer, specialists often prescribe a course of GnRH agonists (such as Lupron or Decapeptyl) for 1 to 3 months. This temporarily lowers estrogen levels, which shrinks adenomyotic lesions and significantly reduces uterine inflammation.
2. Frozen Embryo Transfer (FET) Strategy: Instead of transferring an embryo during a fresh IVF cycle when hormone levels are high from ovarian stimulation, doctors often freeze high-grade embryos. They perform the transfer later in a calm, pre-treated uterine environment.
3. Anti-Inflammatory Therapies: Adjunctive treatments, including targeted protocols or supportive anti-inflammatory medications, help optimize the endometrial lining receptive window.

What Steps Should You Take Next?

If you are planning an IVF journey with adenomyosis, here is how you can take control of your treatment path:

1. Get an Accurate Assessment:

Diagnostic Imaging: Ensure your fertility team performs high-resolution transvaginal 3D ultrasound or an MRI. Precise mapping shows whether your adenomyosis is focal (in one spot) or diffuse (spread across the muscle), which helps guide your treatment protocol design.

2. Discuss Pre-Transfer Suppression:

Medical Consultation: Ask your specialist whether a 1–3-month downregulation protocol before Frozen Embryo Transfer (FET) is appropriate for your specific case.

3. Optimize Overall Pelvic Health:

Lifestyle Support: Adopt an anti-inflammatory diet rich in antioxidants, manage stress levels, and work closely with your medical team to manage symptoms like heavy bleeding or pelvic pain before treatment.

A Note of Reassurance: Thousands of women with adenomyosis have successfully carried pregnancies through modern IVF care. With personalized pre-treatment strategies and expert monitoring, a healthy pregnancy is well within reach.

Disclaimer
This blog is for educational purposes only and does not replace personalized medical advice. Please consult ARTBaby fertility specialists for individual assessment and treatment planning.

The post Adenomyosis and IVF: Can You Still Achieve a Healthy Pregnancy? appeared first on ARTbaby IVF Centre.

Autoimmune diseases occur when the immune system mistakenly attacks the body’s own tissues. Conditions such as systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), rheumatoid arthritis, autoimmune thyroid disease and some other inflammatory disorders can influence fertility, pregnancy planning or pregnancy outcomes.

Importantly, having an autoimmune disease does not automatically mean that IVF will fail or that a healthy pregnancy is impossible. With appropriate preconception assessment, disease control and coordinated medical care, many patients can pursue fertility treatment safely.

For patients considering IVF in India, understanding when immune health matters and when it does not is essential.

How Can Autoimmune Diseases Affect Fertility and Pregnancy?

The relationship between autoimmune disease and fertility is complex. The impact depends on the specific condition, its severity, medications being used, and whether important organs are involved.

Some autoimmune or inflammatory diseases may affect:

• Ovulation or ovarian function
• Menstrual cycles
• The uterine environment
• Implantation and placental development
• Blood-clotting risk
• Pregnancy-related complications
• The safety of certain fertility or pregnancy medications

In some patients, fertility may also be affected indirectly. For example, treatment with certain gonadotoxic medicines can reduce ovarian reserve. This makes fertility preservation before treatment an important consideration for some women with autoimmune disease.

The American College of Rheumatology recommends reproductive planning for patients with rheumatic diseases and emphasizes entering pregnancy when disease activity is low or stable whenever possible.

Autoimmune Conditions That May Require Special Attention

1. Systemic Lupus Erythematosus (SLE)

Lupus can affect multiple organs and may become more difficult to manage during pregnancy in some patients.

Before IVF or pregnancy, doctors may assess disease activity, kidney function, blood pressure, and relevant antibodies. Medication safety is equally important because some medicines used to control autoimmune disease are unsuitable during pregnancy.

The goal is not simply to achieve pregnancy, but to begin pregnancy when the patient’s health is in the safest possible condition.

2. Antiphospholipid Syndrome (APS)

APS deserves particular attention in fertility and pregnancy care.

It is an autoimmune condition associated with abnormal blood clotting and certain pregnancy complications, including recurrent pregnancy loss. Diagnosis requires both appropriate clinical features and persistent antiphospholipid antibodies, not simply a single positive blood test.

Relevant laboratory testing can include:

• Lupus anticoagulant
• Anticardiolipin IgG/IgM
• Anti-beta-2 glycoprotein I IgG/IgM

Current American Society for Reproductive Medicine (ASRM) guidance recommends antiphospholipid antibody evaluation when patients meet appropriate clinical criteria. Confirmed APS may require individualized antithrombotic management during pregnancy.

Patients should not start aspirin or blood thinners on their own. The decision depends on the diagnosis, medical history, and risk of bleeding or thrombosis.

3. Autoimmune Thyroid Disease

Thyroid disorders are relatively common among women of reproductive age.

Conditions such as Hashimoto’s thyroiditis can be associated with hypothyroidism. While the presence of thyroid antibodies alone does not mean that IVF will fail, untreated or inadequately controlled thyroid dysfunction can affect reproductive and pregnancy outcomes.

This is why thyroid function is often assessed as part of fertility and preconception care when clinically indicated.

4. Rheumatoid Arthritis and Other Inflammatory Diseases

Rheumatoid arthritis and other systemic inflammatory conditions do not necessarily prevent IVF.

However, disease activity, medications and associated health problems should be reviewed before treatment. Some medicines may need to be stopped, substituted or adjusted before conception.

The timing of IVF therefore becomes part of the overall medical plan rather than a decision based only on reproductive factors.

Why Immune Health Matters During Pregnancy

Pregnancy requires a highly coordinated interaction between the maternal immune system, placenta, and developing embryo.

The immune system does not simply need to be “strong.” Instead, it needs to maintain an appropriate balance that allows the pregnancy to develop while continuing to protect the mother from infections.

This is an important distinction for IVF patients – A healthy pregnancy does not depend on having an “overactive” or “boosted” immune system.

Autoimmune disease can create additional challenges because abnormal immune activity, inflammation, or blood-clotting mechanisms may contribute to complications in selected patients.

However, the relationship between immune markers and IVF outcomes is complicated, and not every abnormal laboratory result represents a treatable fertility problem.

What Should an IVF Patient With Autoimmune Disease Expect?

A personalized evaluation may include several components.

1. Detailed medical history

The fertility specialist may review:

• Autoimmune diagnosis and duration
• Previous pregnancies and miscarriages
• Previous IVF cycles
• Current medications
• Previous blood clots
• Kidney, liver or other organ involvement
• Disease flares
• Family history
• Previous pregnancy complications

2. Disease activity assessment

For conditions such as lupus or rheumatoid arthritis, controlling active disease before conception is an important part of reproductive planning.

The ACR recommends counseling patients with rheumatic disease about the improved maternal and fetal outcomes associated with entering pregnancy during periods of low disease activity.

3. Medication review

This is particularly important.

Some autoimmune medicines are compatible with pregnancy, while others may pose risks to the developing fetus. Medication changes should therefore be planned before IVF or conception, rather than after pregnancy is established.

Patients should never discontinue prescribed autoimmune medication without consulting the treating specialist.

4. Targeted testing

Testing should be based on the patient’s history and clinical findings.

For example, a patient with recurrent pregnancy loss and clinical features suggestive of APS may require antiphospholipid antibody testing.

In contrast, ordering a large panel of immune tests for every IVF patient is not supported by current evidence.

What About NK Cells, Immune Panels and IVF “Immune Treatments”?

This is an area where patients need particularly clear information.

Commercial fertility testing sometimes promotes investigations such as natural killer (NK) cell testing or broad immune panels, followed by treatments intended to “correct” the immune system.

However, the evidence remains limited.

The 2026 ASRM guidance on recurrent pregnancy loss does not recommend routine immune testing or treatment. Similarly, its 2026 guidance on recurrent implantation failure states that there is insufficient evidence to support routine immunologic therapies such as IVIG, G-CSF or anticoagulation in patients without an appropriate indication.

Earlier ASRM guidance also concluded that immunological testing cannot routinely be recommended for the general ART population because the relationship between immune profiles and IVF outcomes has not been sufficiently established.

This does not mean that immune factors are irrelevant. It means that testing and treatment should be clinically justified rather than automatically added to an IVF package.

Evidence-Based IVF Care for Patients With Autoimmune Disease in India

For an Indian patient with an autoimmune condition, an effective fertility plan may involve collaboration between:

1. Reproductive medicine/fertility specialist to plan ovarian stimulation, embryo creation and transfer.
2. Rheumatologist or relevant specialist to assess disease activity and medication safety.
3. Maternal-fetal medicine or high-risk obstetric specialist, when indicated, particularly for patients with significant systemic disease or pregnancy-risk factors.
4. Hematologist, when clinically appropriate, especially for patients with confirmed APS or significant thrombotic history.

This multidisciplinary approach can be particularly valuable when IVF is being planned after recurrent pregnancy loss, previous implantation failure, or a serious autoimmune diagnosis.

Can IVF Be Successful With an Autoimmune Disease?

Yes, it can.

An autoimmune diagnosis should not automatically be interpreted as a poor IVF prognosis.

The outcome depends on multiple factors, including:

• Maternal age
• Ovarian reserve and response to stimulation
• Egg and sperm quality
• Embryo development
• Chromosomal status where testing is clinically appropriate
• Uterine health
• Underlying autoimmune disease
• Disease activity
• Medication safety
• Previous pregnancy history
• Other medical conditions

For patients with recurrent pregnancy loss, current evidence also emphasizes looking for established causes rather than assuming that an unexplained miscarriage is necessarily an “immune rejection” of the embryo. ASRM’s 2026 guidance recommends a structured evaluation that can include chromosome assessment, uterine evaluation and targeted APS testing when clinically indicated.

How ARTBaby Approaches Patient-Centred Fertility Care

For patients seeking IVF in India, the objective should be more than simply completing an IVF cycle.

At ARTBaby, patients with complex reproductive histories can benefit from an individualized approach in which their fertility history, medical conditions and treatment goals are considered together.

If you have an autoimmune disease, tell your fertility specialist about your diagnosis and provide details of all current and previous medications, previous pregnancies, miscarriages, blood-clotting problems and specialist reports.

This information can help the clinical team determine whether additional evaluation or specialist coordination is appropriate.

Questions to Ask Your Fertility Specialist

Before beginning IVF, consider asking:

• Is my autoimmune disease currently stable enough for IVF?
• Do I need clearance from my rheumatologist or another specialist?
• Are my current medications compatible with pregnancy?
• Do I have clinical indications for antiphospholipid antibody testing?
• Could my autoimmune condition or treatment affect ovarian reserve?
• Do I have any additional pregnancy or clotting risks?
• Which tests are genuinely necessary in my situation?
• Are proposed immune treatments supported by good-quality evidence?

The Bottom Line

Autoimmune disease and IVF can coexist, but successful fertility care requires individualized medical planning rather than a one-size-fits-all “immune treatment.”

For some patients, conditions such as lupus or APS require careful disease control, medication review, and specialist monitoring. For others, extensive immune testing may provide little useful information and could lead to unnecessary treatment.

The most important principle is simple: identify genuine medical risks, treat established conditions appropriately, and avoid interventions that lack convincing evidence.

For patients in India considering IVF, an experienced fertility team working alongside the appropriate medical specialists can help turn a complex medical history into a carefully planned fertility journey.

References:

• https://pmc.ncbi.nlm.nih.gov/articles/PMC5831976/

Disclaimer

This article is intended for general educational purposes and should not be considered medical advice, diagnosis or a substitute for consultation with a qualified fertility specialist, rheumatologist or obstetrician. Autoimmune diseases and their treatments vary considerably between patients. IVF protocols, investigations and medications should be recommended only after an individual medical assessment.

The post Autoimmune Diseases and IVF: How Immune Health Influences Pregnancy appeared first on ARTbaby IVF Centre.

Infertility is not always about egg quality, sperm health, or hormone levels. Researchers are increasingly exploring another important factor that may influence IVF outcomes: the uterine (endometrial) microbiome.

Although once believed to be sterile, the uterus is now known to contain a small community of microorganisms. Emerging evidence suggests that the balance of these microbes, particularly the presence of beneficial Lactobacillus species, may influence implantation and early pregnancy. However, this field is still evolving, and many questions remain unanswered.

For couples planning IVF in India, understanding the science behind the uterine microbiome can help them have informed discussions with their fertility specialist. At ARTBaby, evidence-based, individualized fertility care remains the cornerstone of successful treatment.

What Is the Uterine Microbiome?

The uterine microbiome refers to the collection of bacteria naturally present within the endometrium the inner lining of the uterus where embryo implantation occurs.

Unlike the gut microbiome, the uterine microbiome contains relatively few bacteria. Even so, researchers believe these microorganisms may interact with the immune system, influence inflammation, and contribute to endometrial receptivity during embryo implantation.

Why Is the Endometrial Microbiome Important in IVF?

Successful IVF depends on three major factors:

• A healthy embryo
• A receptive endometrium
• Proper synchronization between embryo and uterus

The endometrial microbiome may affect this third component by influencing the environment where implantation occurs.

Researchers are studying whether microbial imbalance contributes to:

• Implantation failure
• Recurrent IVF failure
• Chronic low-grade inflammation
• Poor endometrial receptivity
• Early pregnancy loss

While these associations are promising, experts agree that microbiome testing has not yet become a standard part of IVF evaluation for all patients because evidence is still developing.

Lactobacillus Dominance: Why Does It Matter?

One of the most discussed findings in reproductive microbiome research is Lactobacillus dominance.

Lactobacillus species are considered beneficial because they help:

• Maintain an acidic environment
• Limit growth of harmful bacteria
• Reduce inflammation
• Support immune balance within the reproductive tract

Several studies have found that women whose endometrial microbiome is predominantly composed of Lactobacillus may experience better implantation and pregnancy outcomes than those with lower Lactobacillus levels. However, researchers caution that results are not completely consistent across studies.

What Is Dysbiosis?

Dysbiosis means an imbalance in the normal microbial community.

Instead of beneficial bacteria dominating, other microorganisms may become more abundant, including species associated with inflammation.

Researchers have linked dysbiosis with:

• Reduced implantation rates
• Altered immune responses
• Increased inflammatory markers
• Possible chronic endometritis
• Lower IVF success in some patient groups

However, dysbiosis alone does not necessarily cause infertility, and many women with microbial imbalance still achieve successful pregnancies.

Can the Uterine Microbiome Cause IVF Failure?

Not directly.

IVF success depends on many interconnected factors, including:

• Female age
• Embryo quality
• Genetic health of embryos
• Endometrial thickness
• Hormonal balance
• Male fertility
• Uterine abnormalities
• Lifestyle factors

The microbiome appears to be one possible contributor rather than the sole cause of implantation failure.

Current evidence suggests it should be considered as part of a comprehensive fertility evaluation rather than an isolated explanation.

When Might Microbiome Testing Be Considered?

Routine microbiome testing is not recommended for every IVF patient.

Some fertility specialists may consider additional evaluation in selected situations, such as:

• Recurrent implantation failure
• Multiple unsuccessful IVF cycles
• Recurrent miscarriage
• Suspected chronic endometritis
• Persistent vaginal infections
• Unexplained infertility after standard investigations

The decision should always be individualized based on clinical history.

How Is the Endometrial Microbiome Evaluated?

Specialized fertility centres may use molecular techniques such as:

• Endometrial sampling
• Next-generation sequencing (NGS)
• 16S rRNA sequencing

These tests identify the types and proportions of bacteria present in the endometrium.

Because testing methods and interpretation vary between laboratories, there is currently no universal international standard for defining an “ideal” uterine microbiome.

Can the Microbiome Be Improved?

This is one of the most active areas of fertility research.

Depending on the underlying findings, specialists may recommend:

• Appropriate treatment for confirmed infections
• Management of chronic endometritis
• Selected antibiotics when clinically indicated
• Vaginal probiotics in carefully chosen cases
• Lifestyle measures supporting vaginal health

Importantly, self-medicating with probiotics or antibiotics is not recommended, as unnecessary treatment may further disturb the microbial balance.

A 2025 systematic review found that vaginal probiotics show promise as an adjunct before embryo transfer, but larger, high-quality clinical trials are still needed before routine use can be recommended.

What Does the Latest Research Say?

Recent research has expanded our understanding of the reproductive microbiome.

Current findings suggest:

• The uterus has its own distinct microbial ecosystem.
• Lactobacillus-rich communities may support implantation in some women.
• Dysbiosis may be associated with poorer reproductive outcomes.
• The microbiome likely interacts with immune and inflammatory pathways affecting endometrial receptivity.
• More randomized clinical trials are needed before microbiome-directed treatments become standard IVF practice.

Why This Matters for Indian IVF Patients

India is witnessing increasing rates of infertility due to delayed parenthood, PCOS, endometriosis, obesity, diabetes, environmental exposures, and lifestyle-related stress.

As fertility medicine advances, clinicians are moving beyond conventional investigations to understand subtle biological factors that may influence implantation.

For selected patients, particularly those with repeated IVF failures the uterine microbiome may become one additional piece of the diagnostic puzzle. However, decisions should always be guided by scientific evidence and specialist evaluation rather than trends.

How ARTBaby Supports Evidence-Based Fertility Care

At ARTBaby, fertility treatment is individualized rather than one-size-fits-all.

Depending on each patient’s history, specialists may evaluate:

• Hormonal profile
• Ovarian reserve
• Male fertility
• Uterine health
• Genetic factors where appropriate
• Advanced investigations for recurrent IVF failure when clinically indicated

As reproductive medicine evolves, ARTBaby continues to follow emerging scientific evidence while ensuring that every recommendation is supported by current clinical guidelines and patient-specific needs.

Frequently Asked Questions

Does everyone undergoing IVF need microbiome testing?

No. Most patients achieve successful IVF without it. Testing is generally reserved for selected clinical situations.

Can probiotics improve IVF success?

Current evidence is encouraging but not conclusive. Probiotics should only be used under medical supervision.

Is Lactobacillus always beneficial?

Lactobacillus dominance is generally associated with a healthier reproductive environment, but fertility depends on many factors beyond bacterial composition.

Is the uterine microbiome research settled?

No. It remains an exciting and rapidly evolving area of reproductive medicine. Larger studies are still needed before routine testing and treatment become standard practice.

Final Thoughts

The uterine microbiome represents one of the most promising frontiers in fertility medicine. Research suggests that a healthy, balanced endometrial environment, particularly one enriched with beneficial Lactobacillus species, may support embryo implantation in some women. However, the science is still evolving, and microbiome testing is not yet recommended as a routine investigation for all IVF patients.

For couples facing repeated implantation failure or unexplained infertility, discussing emerging diagnostic options with an experienced fertility specialist may help identify individualized strategies. At ARTBaby, every treatment plan is guided by evidence-based medicine, comprehensive evaluation, and personalized care to maximize the chances of a healthy pregnancy.

Medically Reviewed By

Reviewed by: DR. Sheweta Mishra Choudhary
Fertility & IVF Specialist
ARTbaby IVF Centre, New Delhi

References:

• https://pmc.ncbi.nlm.nih.gov/articles/PMC12901771/

The post The Uterine Microbiome and IVF Success appeared first on ARTbaby IVF Centre.

What is IVF?

IVF is a complex medical procedure that involves several steps:

Ovarian Stimulation: Hormonal medications are administered to stimulate the ovaries to produce multiple eggs.

Egg Retrieval: Once the eggs are mature, a minor surgical procedure is performed to retrieve them from the ovaries.

Fertilization: The retrieved eggs are fertilized with sperm in a laboratory setting. This can be done using traditional insemination or Intracytoplasmic Sperm Injection (ICSI), where a single sperm is injected directly into an egg.

Embryo Culture: The resulting embryos are monitored for several days to assess their development.

Embryo Transfer: One or more healthy embryos are selected and transferred into the uterus, with the hope of implantation and pregnancy.

Read more about: IVF

Read realated: What is doesn’t work?

Are IVF Babies Different?

When discussing whether IVF babies are “normal,” it is essential to define what is meant by “normal.” Generally, IVF babies are as normal as naturally conceived babies in terms of development and health. However, research indicates that there are some differences worth noting.

Health Outcomes

• Birth Defects: Studies have shown that there may be a slightly increased risk of congenital anomalies in IVF babies compared to those conceived naturally. This can be attributed to several factors, including parental age, underlying fertility issues, and the IVF process itself.
• Multiple Births: IVF often leads to multiple pregnancies (twins, triplets, etc.), especially when multiple embryos are transferred. Multiple births are associated with higher risks, including premature birth and low birth weight.
• Long-term Health: Most studies indicate that children conceived through IVF have similar long-term health outcomes as their peers. However, some research suggests a minor increase in the risk of certain conditions, such as childhood cancers or metabolic issues, but these findings are still being investigated.

Psychological and Developmental Aspects

Children conceived through IVF generally develop normally in terms of cognitive, emotional, and social development. Some studies suggest that IVF children may experience unique challenges due to the circumstances of their conception, such as parental anxiety or societal stigma. However, these factors do not inherently indicate abnormal development.

The Role of Parental Factors

It is essential to recognize that many parents seeking IVF have pre-existing fertility issues, which can also impact their children’s health. Factors such as advanced maternal age, genetic conditions, or lifestyle choices (like smoking or obesity) can play a significant role in the health of both the parents and their children, whether conceived naturally or through IVF.

The “Normalcy” of IVF Babies in Society

As IVF becomes more common, the stigma surrounding assisted reproductive technologies is gradually diminishing. Many people now view IVF babies as just as “normal” as those conceived naturally. This shift in perception is essential for fostering an inclusive society where all family-building methods are respected.

Personal Narratives and Societal Views

Personal stories from families who have experienced IVF can shed light on the realities of raising an IVF child. Many parents report that their IVF babies are healthy, happy, and thriving. Sharing these narratives contributes to normalizing IVF and reducing misconceptions.

Read Also: IVF waiting time

References: 

• https://pmc.ncbi.nlm.nih.gov/articles/PMC9773093/

Conclusion

In conclusion, IVF babies are, in many ways, just as normal as those conceived naturally. While there may be slight differences in health outcomes, the vast majority of IVF children grow up healthy and well-adjusted. As societal attitudes continue to evolve, it is essential to foster understanding and acceptance of diverse pathways to parenthood. Ultimately, the love and care provided by parents—regardless of how their children were conceived—are what truly defines a “normal” family.

The post Are IVF babies normal? appeared first on ARTbaby IVF Centre.

Today, that landscape is changing rapidly.

India is experiencing a significant expansion in fertility care, with IVF clinics opening in Tier 2 and Tier 3 cities. This shift is driven by rising infertility rates, greater awareness, improved healthcare infrastructure, technological advancements, and supportive regulations under the Assisted Reproductive Technology (ART) Act. Industry forecasts also project strong growth in India’s fertility services market over the coming years as organized fertility networks continue expanding nationwide.

For patients, this means one important thing: high-quality fertility care is becoming more accessible than ever before.

Why Is India Witnessing a Fertility Boom?

Several social, medical, and economic factors are contributing to the growing demand for fertility services.

1. Delayed Parenthood

Many Indian couples are choosing to marry and start families later than previous generations due to:

• Career priorities
• Higher education
• Financial planning
• Urban lifestyles

Since female fertility naturally declines with age, especially after 35, delayed parenthood has increased the need for assisted reproductive treatments.

2. Lifestyle-Related Fertility Challenges

Modern lifestyles can affect reproductive health in both men and women.

Common contributing factors include:

• PCOS
• Endometriosis
• Obesity
• Diabetes
• Thyroid disorders
• Smoking and alcohol
• Chronic stress
• Poor sleep
• Environmental pollution

Male infertility has also become increasingly recognized, with sperm quality affected by lifestyle and environmental factors.

3. Greater Awareness about Fertility

A decade ago, infertility remained a sensitive topic in many families.

Today:

• Couples seek fertility advice earlier.
• Social media and digital health platforms have improved awareness.
• Fertility education has reduced myths surrounding IVF.
• More people understand that infertility can affect both partners.

Earlier diagnosis often improves treatment outcomes.

Why IVF Is Expanding Beyond Metro Cities

India’s fertility care ecosystem is undergoing one of its biggest transformations. Leading fertility providers are establishing centers in cities such as Meerut, Haldwani, Amritsar, Jamnagar, Patna, Prayagraj, and other emerging healthcare hubs, bringing advanced reproductive medicine closer to patients. Several factors are driving this expansion.

Better Healthcare Infrastructure

Tier 2 cities now offer:

• Modern hospitals
• Improved diagnostic laboratories
• Better imaging facilities
• Skilled fertility specialists
• Advanced embryology laboratories

These improvements make it possible to deliver IVF services with quality standards comparable to larger cities.

Reduced Travel Burden

Previously, couples often had to:

• Travel repeatedly for monitoring
• Take extended leave from work
• Arrange accommodation
• Manage additional travel expenses

With IVF services available closer to home, treatment becomes more convenient, less stressful, and easier to continue consistently.

Improved Affordability

Although IVF remains a specialized treatment, clinics in smaller cities may have lower operating costs, helping reduce overall treatment expenses while maintaining quality standards. This makes fertility care accessible to a wider population.

Growing Acceptance

Infertility is increasingly being recognized as a medical condition rather than a social stigma.

Local access to fertility specialists encourages couples to seek timely evaluation instead of delaying treatment because of embarrassment or misinformation.

Technology Is Supporting Expansion

Modern fertility care is no longer limited by geography.

Today’s IVF centers increasingly use:

• Digital patient records
• Teleconsultations
• Advanced ultrasound systems
• High-quality embryology laboratories
• Time-lapse embryo monitoring
• Cryopreservation facilities
• Improved laboratory quality control

These innovations help standardize care across multiple locations.

Government Regulations Are Improving Patient Confidence

India’s fertility sector has become more structured following implementation of the ART (Regulation) Act, 2021 and related regulations.

More recently, authorities have strengthened oversight by restricting the supply of key IVF laboratory consumables to registered ART clinics and sperm banks, reinforcing quality and patient safety.

For patients, choosing a registered fertility center is essential for receiving treatment that follows recognized legal and clinical standards.

The Rise of Fertility Care in Smaller Cities

The next phase of India’s fertility growth is expected to come from non-metro regions.

Driving factors include:

• Rising disposable income
• Better health insurance awareness
• Digital consultations
• Improved transportation
• Growing trust in fertility medicine
• Increased awareness among primary care doctors

Experts believe that future demand will increasingly come from Tier 2 and Tier 3 cities rather than metropolitan areas alone.

What This Means for Patients

Greater access to IVF allows couples to:

• Seek medical advice earlier
• Reduce treatment delays
• Lower travel-related stress
• Continue treatment without relocating
• Access modern reproductive technologies closer to home

The result is a more patient-centered fertility journey.

How ARTBaby Support Modern Fertility Care?

At ARTBaby, we understand that every fertility journey is unique.

Our approach combines:

• Personalised fertility evaluation
• Evidence-based treatment planning
• Experienced fertility specialists
• Modern IVF laboratory protocols
• Ethical and transparent counseling
• Compassionate patient support

Whether you are considering your first fertility consultation or exploring advanced IVF options, our goal is to provide care that is scientifically sound, transparent, and tailored to your individual needs.

Frequently Asked Questions (FAQs)

Are IVF clinics only available in metro cities?

No. Many reputable IVF centers now operate in Tier 2 and Tier 3 cities, improving access to fertility care across India.

Is IVF treatment equally effective outside metropolitan cities?

Success depends on factors such as maternal age, diagnosis, embryo quality, laboratory standards, and clinical expertise not simply the city’s size. Choosing a registered clinic with experienced specialists is important.

Why are more couples seeking fertility treatment today?

Delayed parenthood, lifestyle-related health conditions, improved awareness, and better access to specialized reproductive care have all contributed to rising demand.

How do I choose the right IVF clinic?

Look for:

• Registered ART clinic
• Experienced fertility specialists
• Modern embryology laboratory
• Transparent counseling
• Individualized treatment plans
• Ethical clinical practices

Final Thoughts

India’s fertility landscape is changing rapidly. Advanced reproductive care is no longer confined to metropolitan hospitals. The expansion of IVF clinics into Tier 2 and Tier 3 cities is improving access, reducing travel burdens, and helping more couples seek timely treatment.

As awareness grows and technology continues to advance, the focus is shifting from simply increasing the number of fertility centres to ensuring high-quality, ethical, and patient-centred care.

At ARTBaby, we are proud to be part of this evolving journey, supporting individuals and couples with evidence-based fertility care, compassionate guidance, and a commitment to helping them move closer to their dream of parenthood.

Disclaimer

This article is intended for educational and informational purposes only and should not be considered medical advice. Fertility treatment recommendations vary based on individual medical history, age, reproductive health, and diagnostic findings. Patients should consult a qualified fertility specialist for personalized evaluation and treatment planning.

The post India’s Fertility Boom: Why IVF Clinics Are Expanding Beyond Metro Cities appeared first on ARTbaby IVF Centre.